Increased mortality rates seen in chronic hepatitis C patients with pre-cirrhotic advanced fibrosis

Deaths not attributed to liver disease; unrelated to direct effects of long-term antiviral treatment

2011-04-08

(Press-News.org) A three-year follow-up study of patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial revealed that increased mortality among patients with advanced chronic hepatitis C who received long-term peginterferon therapy was attributed to non-liver related causes and occurred primarily in patients with bridging fibrosis. No pattern to this excess mortality was evident to researchers, but deaths were unrelated to the peginterferon treatment. Full findings are published in the April issue of Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).

Infection with hepatitis C virus (HCV) is the primary cause of chronic hepatitis in the U.S., and is a major cause of morbidity and mortality resulting from cirrhosis and hepatocellular carcinoma (HCC). According to the Centers for Disease Control and Prevention (CDC), 3.2 million American are infected with chronic HCV which accounts for up to 10,000 deaths annually in the U.S. The standard treatment for chronic HCV is a combination of pegylated interferon and ribavirin—a combination therapy which achieves sustained virological response rates of 40%-80% as reported by the CDC. Though antiviral therapy may decrease the rate of progression and death from chronic HCV, there is currently no beneficial therapy available for patients who fail to respond to standard treatment.

The initial HALT-C Trial—a randomized, controlled study of 1,050 chronic HCV patients with advanced fibrosis (n=622) or cirrhosis (n=428) who failed to achieve a sustained response from prior antiviral therapy—evaluated the effects of low-dose maintenance therapy with peginterferon, compared to no therapy, in slowing disease progression and preventing end-stage liver disease, HCC, and death. The results from the randomized phase showed that long-term peginterferon treatment failed to produce a positive effect on clinical outcomes or death. Furthermore, the authors noted that excess mortality occurred in the treatment group among patients with advanced fibrosis without cirrhosis.

"We followed the trial participants for an additional three years to investigate whether the increased mortality persisted and to explore causes of death," said lead study author Adrian Di Bisceglie, MD, FACP, Chairman of the Department of Internal Medicine at Saint Louis University School of Medicine in Missouri. For the current analysis, a committee of investigators reviewed deaths occurring during and after the HALT-C Trial to determine the cause of death. The committee categorized each death as liver- or non-liver related, and whether or not the death was associated with complications of peginterferon.

Analysis showed that 18% of the trial participants died (122) or underwent liver transplantation (74) over a median of 5.7 years. Two thirds of the deaths (62%) were attributed to end-stage liver disease or HCC and the remaining deaths (38%) were attributed to non-liver-related causes. The cumulative seven-year mortality rate was 20% for patients in the treatment group compared to 15% in the non-treatment control. Researchers observed differences in mortality rates (by seven years) between the treatment and non-treatment groups which were statistically significant for patients with fibrosis (14% and 7%, respectively) compared to those with cirrhosis (28% and 26%, respectively).

Researchers noted that the increase in mortality for patients treated with peginterferon did not emerge until three years into treatment and continued for several years after treatment ceased. The excess mortality in the treatment group was mainly linked to non-liver-related causes. "No specific cause of death accounted for the excess mortality, but deaths were unrelated to direct effects of peginterferon treatment," concluded Dr. Di Bisceglie. Researchers could not identify an excess frequency of any single condition or disease category for cause of non-liver related deaths. Only one death was determined to be a probable result of complications from peginterferon therapy. "Our findings suggest that the long-term use of peginterferon should be evaluated cautiously and that attention to unrelated complications is warranted."

### This study is published in Hepatology. Media wishing to receive a PDF of the article may contact healthnews@wiley.com.

Full citation: "Excess Mortality in Patients With Advanced Chronic Hepatitis C Treated with Long-Term Peginterferon." Adrian Di Bisceglie, Anne Stoddard, Jules Dienstag, Mitchell Shiffman, Leonard Seeff, Herbert L. Bonkovsky, Chihiro Morishima, Elizabeth Wright, Kristen Snow, William Lee, Robert Fontana, Timothy Morgan, and Marc Ghany for the Halt-C Trial Group. Hepatology; Published Online: January 11, 2011 (DOI:10.1002/hep.24169); Print Issue Date: April 2011. http://onlinelibrary.wiley.com/doi/10.1002/hep.24169/abstract

About the Journal Hepatology is the premier publication in the field of liver disease, publishing original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism. Hepatology is published on behalf of the American Association for the Study of Liver Diseases (AASLD). For more information, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1527-3350 .

About Wiley-Blackwell Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

ELSE PRESS RELEASES FROM THIS DATE:

Genetic differences influence the structure of communities

2011-04-08

Scientists from The University of Manchester are among a group of researchers investigating how genetic differences among individuals contribute to the way ecological communities form, interact and change over time. They say that understanding how individuals interact and form sustainable communities can help society to address issues including food security, prevention of disease and the coexistence between humans and nature in a crowded world. Biologists from the Universities of Manchester, York, and St Andrews have edited a special issue of Philosophical Transactions ...

Male victims of 'intimate terrorism' can experience damaging psychological effects

2011-04-08

WASHINGTON – Men who are abused by their female partners can suffer significant psychological trauma, such as post-traumatic stress disorder, depression and suicidal thoughts, according to two new papers published by the American Psychological Association. Although most reported domestic abuse is committed by men against women, a growing body of research has picked up on the prevalence and significance of domestic violence perpetrated against men, says research published in the April issue of Psychology of Men & Masculinity. "Given the stigma surrounding this issue and ...

VitaKine platelet cell therapy from bioparadox improves cardiac function after heart attack

2011-04-08

Menlo Park, Calif.—April 7, 2011—BioParadox, Inc., a regenerative medicine company pioneering point-of-care biologic treatments for cardiovascular disease, today announced data supporting the use of VitaKine® Platelet Cell Therapy (PCT) as a promising treatment for heart attack patients. The results of a preclinical cardiac study were presented at the 2nd Annual Translational Regenerative Medicine Forum in Washington, D.C. Platelet-Rich Plasma (PRP), a component of whole blood, has been shown to effectively treat sports-related injuries such as chronic tennis elbow in ...

Sand drift explained

2011-04-08

Researchers in countries such as Denmark, the Netherlands and Poland study sand drift, but most of them are focusing on sand dunes along the coastline, not on the plains further inland. "Sand dunes are dynamic. For all we know, they may have been formed last year. But sand plaines are much older and in periods more stable. Thin organic layers present in sands are interesting, when trying to understand sand drift in pre-historic times," says botanist Lisbeth Prøsch-Danielsen at the University of Stavanger's Museum of Archaeology. Together with her colleague, geologist ...

VA makes major gains in quality, but racial disparity persists

2011-04-08

PROVIDENCE, R.I. [Brown University] — As recently as the 1990s, the Veterans Affairs health care system had a subpar reputation for quality, but two new studies of standard quality metrics, both led by Amal Trivedi, assistant professor of community health at Brown University and a physician at the Providence VA Medical Center, show that the system that cares for more than 5 million patients has improved markedly in the last decade. In one study, published online March 18 in the journal Medical Care, Trivedi found that the VA's care for seniors is consistently better than ...

Deep-space travel could create heart woes for astronauts

2011-04-08

Astronauts anticipate more trips to the moon and manned missions to Mars. But exposure to cosmic radiation outside the Earth's magnetic field could be detrimental to their arteries, according to a study by University of Alabama at Birmingham researchers published April 6, 2011, online in the journal Radiation Research. Using an animal model, researchers assessed the affect of iron ion radiation commonly found in outer space to see if exposures promoted the development of atherosclerosis, as terrestrial sources of radiation are known to do. They observed that cosmic radiation ...

Michigan's collaborative quality improvement program cuts costs, improves patient care

2011-04-08

Ann Arbor, Mich. -- In a paper published today in the professional health care journal, Health Affairs, Blue Cross Blue Shield of Michigan and the University of Michigan Health System report that their model for collaborative health care quality improvement has measurably improved safety and quality in several clinical areas, and has saved millions in health care costs. Collaborative quality initiatives, the term given to the payer-hospital initiatives aimed at improving safety and quality of specific surgical procedures and clinical practices, have been shown to outpace ...

Scientists have new measure for species threat

2011-04-08

A new index has been developed to help conservationists better understand how close species are to extinction. The index, developed by a team of Australian researchers from the University of Adelaide and James Cook University, is called SAFE (Species Ability to Forestall Extinction). The SAFE index builds on previous studies into the minimum population sizes needed by species to survive in the wild. It measures how close species are to their minimum viable population size. "SAFE is a leap forward in how we measure relative threat risk among species," says co-author ...

Number of days of rain in Iberian Peninsula has increased since 1903

2011-04-08

A research team, led by the University of Extremadura, has for the first time analysed the frequency of rainfall over the whole of the Iberian Peninsula from 1903 to 2003. The results show that the number of rainy days increased over the 20th Century, except in the area of the Gulf of Cádiz and in western Portugal. However, rainfall has become less and less intense, except in these two regions. The study, which used daily precipitation data from 27 stations in Spain and Portugal, provides the first long-term evaluation of changes to rainfall over the Iberian Peninsula. ...

Climate change poses major risks for unprepared cities

2011-04-08

Cities worldwide are failing to take necessary steps to protect residents from the likely impacts of climate change, even though billions of urban dwellers are vulnerable to heat waves, sea level rise and other changes associated with warming temperatures. A new examination of urban policies by Patricia Romero Lankao at the National Center for Atmospheric Research (NCAR) in Boulder, Colo., in conjunction with an international research project on cities and climate change, warns that many of the world's fast-growing urban areas, especially in developing countries, will ...

Increased mortality rates seen in chronic hepatitis C patients with pre-cirrhotic advanced fibrosis

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: